Altimmune Inc (ALT) Stock Price, Quote, News & History

ALTNASDAQ
$3.47
0.061.76%
At close: Apr 22, 5:00 PM EST
$3.05
-0.42-12.10%
After Hours: 7:59 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-67.54M
Investing Cash Flow (TTM)
-132.47M
Financing Cash Flow (TTM)
206.84M
Free Cash Flow (TTM)
-67.55M
Capital Expenditure (TTM)
-11.00K
Net Change in Cash (TTM)
6.83M

Analyst Trends and Forecast

0
0
0
0
Nov 25
2
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$204.59M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
7306.20
PB Ratio (TTM)
1.97
Earnings Yield % (TTM)
-29.41%
Earnings Yield % (FWD)
-28.53%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.73

Company Debt

Total Debt
$34.29M
LT Debt
$34.29M
LT Debt Issuance (TTM)
$35.00M
LT Debt Repayment (TTM)
-
Total Cash
$43.76M
Debt to Equity
0.16
Issuance of Debt (TTM)
$35.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.45
Close
$3.47
Volume / Avg.
2.95M / 3.80M
Day Range
$3.42 - $3.51
52 Wk Range
2.87 - 7.73
Market Cap
$396.82M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
22.52%
Days to Cover
7.65

About

Sector
Health Care
Industry
Biotechnology
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Altimmune (ALT) stock?

A

You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Altimmune (ALT) stock?

A

Altimmune has a consensus price target of $18.36.

Q

What is the current price for Altimmune (ALT)?

A

The stock price for Altimmune (NASDAQ: ALT) is $3.05 last updated April 22, 2026 at 7:59 PM EDT.

Q

Does Altimmune (ALT) pay a dividend?

A

There are no upcoming dividends for Altimmune.

Q

When is Altimmune (NASDAQ:ALT) reporting earnings?

A

Altimmune does not have any upcoming earnings scheduled.

Q

Is Altimmune (ALT) going to split?

A

There is no upcoming split for Altimmune.

Q

What sector and industry does Altimmune (ALT) operate in?

A

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.